Medtronic (MDT) closed at $79.30 in the latest trading session, marking a -0.23% move from the prior day.
If the prospect of controlling computers and robots with brainpower alone excites you, neurotech stocks are right up your alley. Unfortunately, today's top neurotech company — Elon Musk's Neuralink — remains off-limits to retail investors.
Investing in stocks carries risks, but not investing can also be risky, especially with potential declines in savings account yields. Medtronic is a strong dividend aristocrat with top-line growth, profitability, and new product opportunities in the healthcare tech sector. MDT remains a good value stock with strong financials, dividend growth, and potential for market-beating returns.
Medtronic (MDT) closed the most recent trading day at $78.10, moving +1.32% from the previous trading session.
The medical-device specialist habitually declares dividend raises. This year's model is quite modest, though, so buyer beware.
Medtronic is a global leader in medical therapies, with portfolios in cardiovascular, neuroscience, medical surgical, and diabetes segments. My investment thesis is based on market leadership, a robust pipeline, and a strong balance sheet for M&A, with a bullish outlook on future growth. MDT has underperformed in recent years, but with earnings growth and a strong pipeline, I consider shares to be cheap.
While the pairing of artificial intelligence and healthcare may sound like something straight out of a science fiction movie, there are several avenues through which the high-speed data processing offered by AI can improve patient outcomes. From more precise diagnosis to pandemic modeling, the large-scale algorithmic models we call AI can help the world of medicine immensely.
The latest trading day saw Medtronic (MDT) settling at $77.06, representing a +0.23% change from its previous close.
The remarkable advancements in automation, powered by robotics, have put several robotics stocks to buy on investors' radar. In recent years, the mushrooming power, utility and functionality of artificial intelligence have accelerated the use of robotics across several industries.
If this year's market volatility has you feeling uneasy, you're not alone. The overvaluation of many tech stocks has created a challenging environment, but plenty of affordable, undervalued blue-chip stocks can provide the stability your portfolio needs.
Medtronic's (MDT) stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.
Medtronic (MDT) presents more compelling data showcasing the benefits of the MiniMed 780G system.